These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30775484)

  • 21. Trabecular bone deterioration in differentiated thyroid cancer: Impact of long-term TSH suppressive therapy.
    Hawkins Carranza F; Guadalix Iglesias S; Luisa De Mingo Domínguez M; Martín-Arriscado Arroba C; López Álvarez B; Allo Miguel G; Martínez Díaz-Guerra G
    Cancer Med; 2020 Aug; 9(16):5746-5755. PubMed ID: 32583973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone mineral density after surgical treatment for Graves' disease.
    Arata N; Momotani N; Maruyama H; Saruta T; Tsukatani K; Kubo A; Ikemoto K; Ito K
    Thyroid; 1997 Aug; 7(4):547-54. PubMed ID: 9292941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical characteristics of Graves
    Mo J; Fu L; Zheng Y; Peng S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jan; 46(1):47-52. PubMed ID: 33678636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of Bone Mineral Density Using DXA and cQCT in Postmenopausal Patients Under Thyrotropin Suppressive Therapy.
    Kim K; Kim IJ; Pak K; Kim SJ; Shin S; Kim BH; Kim SS; Lee BJ; Jeon YK
    J Clin Endocrinol Metab; 2018 Nov; 103(11):4232-4240. PubMed ID: 29982711
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.
    Kumeda Y; Inaba M; Tahara H; Kurioka Y; Ishikawa T; Morii H; Nishizawa Y
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4157-61. PubMed ID: 11095447
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low trabecular bone score in postmenopausal women with differentiated thyroid carcinoma after long-term TSH suppressive therapy.
    De Mingo Dominguez ML; Guadalix Iglesias S; Martin-Arriscado Arroba C; López Alvarez B; Martínez Diaz-Guerra G; Martinez-Pueyo JI; Ferrero Herrero E; Hawkins Carranza F
    Endocrine; 2018 Oct; 62(1):166-173. PubMed ID: 30014437
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.
    Ongphiphadhanakul B; Puavilai G; Rajatanavin R
    J Med Assoc Thai; 1996 Sep; 79(9):563-7. PubMed ID: 8996984
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Skeletal integrity in premenopausal and postmenopausal women receiving long-term L-thyroxine therapy.
    Greenspan SL; Greenspan FS; Resnick NM; Block JE; Friedlander AL; Genant HK
    Am J Med; 1991 Jul; 91(1):5-14. PubMed ID: 1858829
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Can bone loss be reversed by antithyroid drug therapy in premenopausal women with Graves' disease?
    Belsing TZ; Tofteng C; Langdahl BL; Charles P; Feldt-Rasmussen U
    Nutr Metab (Lond); 2010 Sep; 7():72. PubMed ID: 20807449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Change in bone mineral density in patients with hyperthyroidism after attainment of euthyroidism by dual energy X-ray absorptiometry.
    Wakasugi M; Wakao R; Tawata M; Gan N; Inoue M; Koizumi K; Onaya T
    Thyroid; 1994; 4(2):179-82. PubMed ID: 7920000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Studies of thyroid function and immune parameters in patients with hyperthyroid Graves' disease in remission.
    Murakami M; Koizumi Y; Aizawa T; Yamada T; Takahashi Y; Watanabe T; Kamoi K
    J Clin Endocrinol Metab; 1988 Jan; 66(1):103-8. PubMed ID: 3121661
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Association of Thyroid Stimulating Hormone Receptor Antibody Levels with Disease Severity in the Chronic Inactive Stage of Graves' Orbitopathy.
    Woo YJ; Jang SY; Lim TH; Yoon JS
    Korean J Ophthalmol; 2015 Aug; 29(4):213-9. PubMed ID: 26240504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy With Intravenous Methylprednisolone Pulses Is Associated With Loss of Bone Microarchitecture in Trabecular Bone Score -Assessment Among Patients With Moderate-to-Severe Graves' Orbitopathy: A Pilot Study.
    Rymuza J; Pelewicz K; Przedlacki J; Miśkiewicz P
    Front Endocrinol (Lausanne); 2022; 13():893600. PubMed ID: 35909547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnostic testing for Graves' or non-Graves' hyperthyroidism: A comparison of two thyrotropin receptor antibody immunoassays with thyroid scintigraphy and ultrasonography.
    Scappaticcio L; Trimboli P; Keller F; Imperiali M; Piccardo A; Giovanella L
    Clin Endocrinol (Oxf); 2020 Feb; 92(2):169-178. PubMed ID: 31742747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyrotropin versus thyroid hormone in regulating bone density and turnover in premenopausal women.
    Baqi L; Payer J; Killinger Z; Hruzikova P; Cierny D; Susienkova K; Langer P
    Endocr Regul; 2010 Apr; 44(2):57-63. PubMed ID: 20429634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of the 2nd generation assay for anti-TSH receptor antibodies to differentiate relapse of Graves' thyrotoxicosis from development of painless thyroiditis after antithyroid drug treatment for Graves' disease.
    Izumi Y; Takeoka K; Amino N
    Endocr J; 2005 Aug; 52(4):493-7. PubMed ID: 16127219
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Fluctuations in the titers of anti-thyroid hormone and anti-thyroglobulin antibodies in 4 cases of Graves' disease during long-term treatment period].
    Komaki T; Sakata S; Nakamura S; Matsuda M; Kojima N; Takuno H; Miura K
    Nihon Naibunpi Gakkai Zasshi; 1989 Jul; 65(7):627-39. PubMed ID: 2583311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects.
    Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K
    J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease.
    Matsuura N; Harada S; Ohyama Y; Shibayama K; Fukushi M; Ishikawa N; Yuri K; Nakanishi M; Yokota Y; Kazahari K; Oguchi H
    Pediatr Res; 1997 Aug; 42(2):214-8. PubMed ID: 9262225
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is trabecular bone score less affected by degenerative-changes at the spine than lumbar spine BMD?
    Anderson KB; Holloway-Kew KL; Mohebbi M; Kotowicz MA; Hans D; Pasco JA
    Arch Osteoporos; 2018 Nov; 13(1):127. PubMed ID: 30446835
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.